Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZ439 blood-stage malaria challenge study
ACTRN12612000814875Phase 2Completed
- Sponsor
- QIMR Berghofer Medical Research Institute
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of artefenomel in malaria (3 cohorts), sponsored by QIMR Berghofer Medical Research Institute. Primary endpoint: Pharmacokinetic-pharmacodynamic relationship of OZ439 on parasite clearance. Started Sep 2012; status: completed.
02
Drugs
artefenomel
03
Conditions
malaria
Beyond the preview
Go deeper on ACTRN12612000814875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000814875.